Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.66 USD | +3.14% | +4.88% | +34.06% |
19/04 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
01/04 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.06% | 2.32B | |
+11.93% | 3,096B | |
+12.04% | 85.37B | |
+6.72% | 77.1B | |
-13.71% | 54.31B | |
-22.79% | 47.92B | |
+24.78% | 47.74B | |
+19.46% | 42.15B | |
+69.31% | 38.06B | |
-9.16% | 24.73B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Deutsche Bank Adjusts Cellebrite's Price Target to $7 From $10, Maintains Buy Rating